HDAC9 and Parkinson disease: In both cultured cells and transgenic fly lines, the administration of two different HDAC inhibitors, NaB or SAHA, which showed efficacy for HD, also showed significant protection against α-synuclein-dependent neurotoxicity in PD [102].